corrigendum to Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas [Carcinogenesis 27 (5)(2006): 1081-1089;] doi:10.1093/carcin/bgi331;Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas

Carcinogenesis

Volumn 27, Issue 5, 2006, Pages 1081-1089

  Matabuena de Yzaguirre, M ^a   Santos Hernandez J ^a   Fernandez Navarro P ^a   Lopez Nieva P ^a   Herranz, M ^b   Fraga, M F ^b   Esteller, M ^b   Juarranz, A ^a   Fernandez Piqueras J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL FRACTIONATION; CONTROLLED STUDY; EPIGENETICS; FEMALE; GAMMA RADIATION; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; THYMUS LYMPHOMA;

EID: 33646199743     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgw051     Document Type: Erratum

References (44)

1. Brathwaite,O., Bayona,W. and Newcomb,E. (1992) p53 mutations in C57BL/6J murine thymic lymphomas induced by γ-irradiation and N-methylnitrosourea. Cancer Res., 52, 3791-3795.
2. Malumbres,M., Perez de Castro,I., Santos,J., Melendez,B., Mangues,R., Serrano,M., Pellicer,A. and Fernández-Piqueras,J. (1997) Inactivation of the cyclin-dependent kinase inhibitor pl5INK4b by deletion and de novo methylation with independence of p161NK4a alterations in murine primary T-cell lymphomas. Oncogene, 14, 1361-1370.
3. Malumbres,M., Perez de Castro,I., Santos,J., Fernández-Piqueras,J. and Pellicer,A. (1999) Hypermethylation of the cell-cycle inhibitor p15INK4b 3′-untranslated region interferes with its transcriptional regulation in primary lymphomas. Oncogene, 18, 385-396.
4. Herranz,M., Santos,J., Salido,E., Fernández-Piqueras,J. and Serrano,M. (1999) Mouse p73 gene maps to the distal part of chromosome 4 and might be involved in the progression of γ-radiation-induced T-cell lymphomas. Cancer Res., 59, 2068-2071.
5. ARF promoter CpG island and its methylation pattern in primary lymphomas. Carcinogenesis, 21, 817-821.
6. Pérez de Castro,I., Malumbres,M., Santos,J., Pellicer,A. and Fernandez-Piqueras,J. (1999) Cooperative alterations of Rb-pathway regulators in mouse primary T-cell lymphomas. Carcinogenesis, 20, 1675-1682.
7. Santos,J., Herranz,M., Fernández,M., Vaquero,C., López,P. and Fernández-Piqueras,J. (2001) Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in γ-radiation-induced thymic lymphomas. Oncogene, 20, 2186-2189.
8. Kakinuma,S., Nishimura,M., Sasanuma,S.-I., Mita,K., Suzuki,G., Katsura,Y., Sado,T. and Shimada,Y. (2002) Spectrum of Znfn1a1 (Ikaros) inactivation and its association with loss of heterozygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice. Rad. Res., 157, 331-340.
9. IC -induced T cell leukemogenesis. Cancer Cell, 3, 551-564.
10. Tsuji,H., Ishii-Ohba,H., Ukai,H., Katsube,T. and Ogiu,T. (2003) Radiation-induced deletions in the 5′ end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas. Carcinogenesis, 24, 1257-1268.
11. López,P., Santos,J. and Fernández-Piqueras,J. (2004) Defective expression of Notch1 and Notch2 in connection to alterations of c-Myc and Ikaros in gamma-radiation-induced mouse thymic lymphomas. Carcinogenesis, 7, 1299-1304.
12. Wakabayashi,Y., Watanabe,H., Inoue,J. et al. (2003) Bcl1 1b is required for differentiation and survival of αβ T lymphocytes. Nature Immunol., 4, 533-539.
13. Anderson,G. and Jenkinson,E.J. (2001) Lymphostromal interactions in thymic development and function. Nature Rev. Immunol., 1, 31-40.
14. Cavallaro,U. and Christofori,G. (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nature Rev. Cancer, 4, 118-132.
15. Nelson,W.J. and Nusse,R. (2004) Convergente of Wnt, β-Catenin, and Cadherin pathways. Science, 303, 1483-1487.
16. Lee,M.G., Sharrow,S.O., Farr,A.G., Singer,A. and Udey,M.C. (1994) Expression of the homotypic adhesion molecule E-cadherin by immature murine thymocytes and thymic epithelial cells. J. Immunol., 152, 5653-5659.
17. Munro,S.B., Duclos,A.J., Jackson,A.R., Baines,M.J. and Blaschuk,O.W. (1996) Characterization of cadherins expressed by murine thymocytes. Cell Immunol., 169, 309-312.
18. Muller,K.M., Luedecker,C.J., Udey,M.C. and Farr,A.G. (1997) Involvement of E-cadherin in thymus organogenesis and thymoryte maturation. Immunity, 6, 257-264.
19. Kutlesa,S., Wessels,J.T., Speiser,A., Steiert,I., Muller,C.A. and Klein,G. (2002) E-cadherin mediated interactions of thymic epithelial cells with CD103+ thymocytes lead to enhanced thymocyte cell proliferation. J. Cell Sci., 115, 4505-4515.
20. Puch,S., Armeanu,S., Kibler,C., Johnson,K.R., Muller,C.A., Wheelock,M.J. and Klein,G. (2001) N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J. Cell Sci., 114, 1567-1577.
21. Melki,J.R., Vincent,P.C., Brown,R.D. and Clark,S.J. (2000) Hypermethylation of E-cadherin in leukemia. Blood, 15, 3208-3213.
22. Ohshima,K., Haraoka,S., Yoshioka,S., Kawasali,C., Tutiya,T., Suzumiya,J. and Kikuchi,M. (2001) Chromosome 16q deletion and loss of E-cadherin expression in Hodgkin and Reed-Sternberg cells. Int. J. Cancer, 92, 678-682.
23. Tsutsui,J., Moriyama,M., Arima,N., Ohtsubo,H., Tanaka,H. and Ozawa,M. (1996) Expression of cadherin-catenin complexes in human leukaemia cell lines. J. Biochem., 120, 1034-1039.
24. Kawamura-Kodama,K., Tsutsui,J., Suzuki,S.T., Kanzaki,T. and Ozawa,M. (1999) N-cadherin expressed on malignant T cell lymphoma cells is functional, and promotes heterotypic adhesion between the lymphoma. cells and mesenchymal cells expressing N-cadherin. J. Inves. Dermatol., 112,62-66.
25. Santos,J., Perez de Castro,I., Herranz,M., Pellicer,A. and Fernandez-Piqueras,J. (1996) Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas. Oncogene, 3,669-676.
26. Gray,D.H.D., Chidgey,A.P. and Boyd,R.L. (2002) Analysis of thymic stromal cell populations using flow cytometry. J. Immunol. Methods, 260, 15-28.
27. Sospedra,M., Ferrer-Francesch,X., Dominguez,O., Juan,M., Foz-Sala,M. and Pujol-Borrell,R. (1998) Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J. Immunol., 161, 5918-5929.
28. Herman,J.G., Graff,J.R., Myohanen,S., Nelkin,B.D. and Baylin,S.B. (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.
29. Di Croce,L. and Pelicci,P.G. (2003) Tumour-associated hypermethylation: silencing E-cadherin expression enhances invasion and metastasis. Eur. J. Cancer, 39, 413-414.
30. Hagihara,A., Miyamoto,K., Furuta,J., Hiraoka,N., Wakazono,K., Seki,S., Fukushima,S., Tsao,M.S., Sugimura,T. and Ushijima,T. (2004) Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene, 23, 8705-8710.
31. Tomita,K., van Bokhoven,A., van Leenders,G.J., Ruijter,E.T., Jansen,C.F., Bussemakers,M.J. and Schalken,J.A. (2000) Cadherin switching in human prostate cancer progression. Cancer Res., 60, 3650-3654.
32. Lee,G. and Herlyn,M. (2000) Dynamics of intercellular communication during melanoma development. Mol. Med. Today, 6, 163-169.
33. Hazan,R.B., Kang,L., Whooley,B.P. and Borgen,P.I. (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes. Commun., 4, 399-411.
34. Hazan,R.B., Philips,G.R., Qiao,R.F., Norton,L. and Aaronson,S.A. (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol., 148, 779-790.
35. Matabuena,M., Santos,J. and Fernández-Piqueras,J. (2004) Evidence for a new tumour suppressor gene locus for (-radiation-induced thymic lymphoma located on the proximal part of mouse chromosome 18. Rev. Oncol., 6, 90-93.
36. Esteller,M. (2003) Relevance of DNA methylation in the management of cancer. Lancet Oncol., 4, 351-358.
37. Cano,A., Pérez-Moreno,M.A., Rodrigo,I., Locascio,A., Blanco,M.J., del Barrio,M.G., Portillo,F. and Nieto,M.A. (2000) The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biol., 2, 76-83.
38. Tycko,B. (2000) Epigenetic gene silencing in cancer. J. Clin. Invest., 105, 401-407.
39. Peinado,H., Quintanilla,M. and Cano,A. (2003) Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem., 278, 21113.
40. Peinado,H., Ballestar,E., Esteller,M. and Cano,A. (2004a) Snail mediates E-cadherin repression by recruitment of the Sin3A/Histone deacetylase (HDAC1)/HDAC2 complex. Mol. Cell. Biol., 24, 306-319.
41. Peinado,H., Portillo,F. and Cano,A. (2004b) Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol., 48, 365-375.
42. Stemmler,M.P., Hecht,A. and Kemler,R. (2005) E-cadherin intron 2 contains cis-regulatory elements essential for gene expression. Development, 132,965-976.
43. Kurose,K., Gilley,K., Matsumoto,S., Watson,P.H., Zhou,X.-P. and Eng,C. (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet., 32, 355-357.
44. Herranz,M., Martin-Caballero,J., Fraga,M.F., Ruiz-Cabello,J., Flores,J.M., Desco,M., Marquez,V. and Esteller,M. (2006) The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma. Blood, 107, 1175-1177.